Patrick Donnelly
Stock Analyst at Citigroup
(3.85)
# 695
Out of 5,131 analysts
357
Total ratings
55.21%
Success rate
7.73%
Average return
Main Sectors:
Stocks Rated by Patrick Donnelly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRA Natera | Initiates: Buy | $300 | $235.45 | +27.42% | 1 | Jan 7, 2026 | |
| GH Guardant Health | Maintains: Buy | $100 → $135 | $107.57 | +25.50% | 11 | Dec 11, 2025 | |
| TXG 10x Genomics | Downgrades: Neutral | $18 | $19.80 | -9.09% | 13 | Dec 11, 2025 | |
| TMO Thermo Fisher Scientific | Upgrades: Buy | $580 → $660 | $615.45 | +7.24% | 21 | Dec 11, 2025 | |
| QGEN Qiagen | Downgrades: Neutral | $52 → $48 | $47.26 | +0.76% | 14 | Dec 11, 2025 | |
| FTRE Fortrea Holdings | Upgrades: Buy | $12 → $21 | $18.41 | +14.07% | 5 | Dec 11, 2025 | |
| A Agilent Technologies | Maintains: Buy | $165 → $185 | $147.99 | +25.01% | 27 | Nov 25, 2025 | |
| MTD Mettler-Toledo International | Maintains: Buy | $1,600 → $1,700 | $1,491.99 | +13.94% | 15 | Nov 10, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Buy | $350 → $375 | $322.90 | +16.14% | 17 | Oct 30, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Buy | $350 → $375 | $324.85 | +15.44% | 17 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $200 → $230 | $240.86 | -4.51% | 13 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $40 → $33 | $33.39 | -1.17% | 6 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $225 → $200 | $180.03 | +11.09% | 10 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $55 → $70 | $66.51 | +5.25% | 12 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $42 | $25.60 | +64.06% | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $40 → $38 | $53.42 | -28.87% | 17 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $150 → $200 | $218.93 | -8.65% | 21 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $60 → $80 | $74.85 | +6.88% | 15 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $85 → $80 | $145.55 | -45.04% | 17 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $22 → $18 | $12.28 | +46.58% | 8 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $185 | $175.94 | +5.15% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $265 | $239.00 | +10.88% | 12 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $20 | $18.98 | +5.37% | 3 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $102.25 | -26.65% | 13 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $28 | $20.68 | +35.40% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $145 | $103.89 | +39.57% | 1 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $265 → $300 | $393.67 | -23.79% | 24 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $2.69 | +234.57% | 6 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.75 → $2.75 | $3.60 | -23.61% | 4 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $250 → $260 | $250.39 | +3.84% | 11 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6 | $8.56 | -29.91% | 4 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $28 → $32 | $6.57 | +387.06% | 2 | Nov 30, 2018 |
Natera
Jan 7, 2026
Initiates: Buy
Price Target: $300
Current: $235.45
Upside: +27.42%
Guardant Health
Dec 11, 2025
Maintains: Buy
Price Target: $100 → $135
Current: $107.57
Upside: +25.50%
10x Genomics
Dec 11, 2025
Downgrades: Neutral
Price Target: $18
Current: $19.80
Upside: -9.09%
Thermo Fisher Scientific
Dec 11, 2025
Upgrades: Buy
Price Target: $580 → $660
Current: $615.45
Upside: +7.24%
Qiagen
Dec 11, 2025
Downgrades: Neutral
Price Target: $52 → $48
Current: $47.26
Upside: +0.76%
Fortrea Holdings
Dec 11, 2025
Upgrades: Buy
Price Target: $12 → $21
Current: $18.41
Upside: +14.07%
Agilent Technologies
Nov 25, 2025
Maintains: Buy
Price Target: $165 → $185
Current: $147.99
Upside: +25.01%
Mettler-Toledo International
Nov 10, 2025
Maintains: Buy
Price Target: $1,600 → $1,700
Current: $1,491.99
Upside: +13.94%
Bio-Rad Laboratories
Oct 30, 2025
Maintains: Buy
Price Target: $350 → $375
Current: $322.90
Upside: +16.14%
Bio-Rad Laboratories
Oct 30, 2025
Maintains: Buy
Price Target: $350 → $375
Current: $324.85
Upside: +15.44%
Oct 29, 2025
Maintains: Neutral
Price Target: $200 → $230
Current: $240.86
Upside: -4.51%
Oct 7, 2025
Downgrades: Neutral
Price Target: $40 → $33
Current: $33.39
Upside: -1.17%
Aug 21, 2025
Downgrades: Neutral
Price Target: $225 → $200
Current: $180.03
Upside: +11.09%
Aug 21, 2025
Upgrades: Buy
Price Target: $55 → $70
Current: $66.51
Upside: +5.25%
Aug 13, 2025
Maintains: Buy
Price Target: $34 → $42
Current: $25.60
Upside: +64.06%
Aug 4, 2025
Maintains: Neutral
Price Target: $40 → $38
Current: $53.42
Upside: -28.87%
Jul 9, 2025
Upgrades: Buy
Price Target: $150 → $200
Current: $218.93
Upside: -8.65%
Jul 9, 2025
Upgrades: Buy
Price Target: $60 → $80
Current: $74.85
Upside: +6.88%
Jul 9, 2025
Downgrades: Sell
Price Target: $85 → $80
Current: $145.55
Upside: -45.04%
Mar 4, 2025
Maintains: Neutral
Price Target: $22 → $18
Current: $12.28
Upside: +46.58%
Mar 4, 2025
Downgrades: Neutral
Price Target: $185
Current: $175.94
Upside: +5.15%
Jan 30, 2025
Maintains: Buy
Price Target: $285 → $265
Current: $239.00
Upside: +10.88%
Nov 6, 2024
Maintains: Buy
Price Target: $18 → $20
Current: $18.98
Upside: +5.37%
Nov 6, 2024
Maintains: Buy
Price Target: $80 → $75
Current: $102.25
Upside: -26.65%
Aug 7, 2024
Maintains: Buy
Price Target: $30 → $28
Current: $20.68
Upside: +35.40%
Jul 30, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $103.89
Upside: +39.57%
Dec 11, 2023
Maintains: Neutral
Price Target: $265 → $300
Current: $393.67
Upside: -23.79%
Dec 11, 2023
Maintains: Buy
Price Target: $7 → $9
Current: $2.69
Upside: +234.57%
Aug 10, 2023
Maintains: Neutral
Price Target: $3.75 → $2.75
Current: $3.60
Upside: -23.61%
Feb 17, 2023
Maintains: Neutral
Price Target: $250 → $260
Current: $250.39
Upside: +3.84%
Nov 3, 2022
Maintains: Buy
Price Target: $8 → $6
Current: $8.56
Upside: -29.91%
Nov 30, 2018
Upgrades: Neutral
Price Target: $28 → $32
Current: $6.57
Upside: +387.06%